Pulmonx Corp (FRA:4NI)
€ 6.7 0.15 (2.29%) Market Cap: 278.26 Mil Enterprise Value: 229.75 Mil PE Ratio: 0 PB Ratio: 3.17 GF Score: 58/100

Pulmonx Corp at Bank of America Global Healthcare Conference Transcript

May 09, 2023 / 10:55PM GMT
Release Date Price: €11.2
Travis Lee Steed
BofA Securities, Research Division - MD

All right. Good afternoon, everybody. Travis Steed, Medical Device Analyst at Bank of America. And we have Pulmonx up next, Glen French, CEO; and Derrick Sung, CFO.

Questions & Answers

Travis Lee Steed
BofA Securities, Research Division - MD

Maybe just -- you just reported Q1 last week. Maybe walk through the quarter, anything different between January, February, March, April? Just kind of walk through a little bit kind of some momentum we saw in Q1 in the overall environment.

Glendon E. French
Pulmonx Corporation - CEO, President & Director

Yes. So the quarter went pretty much as we had anticipated. We had a -- we came into the quarter, and as has been the case over prior years, we had a soft entry into the quarter as people got up and running after the holidays. So the first half of January was pretty soft and then strengthened across the balance of January and continued to strengthen in February and March and nice exit out of the period and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot